NSEMonitoring Agency Report2d ago · 10 Nov 2026, 11:10 am

Monitoring Agency Report

Paramount Communications Limited · PARACABLES

✦ AI SummaryResults

Paramount Communications Limited has received a Monitoring Agency Report for the quarter ended September 30, 2026, from CARE Ratings Limited, which states that there is no deviation from the objects of the issue. The report provides an objective view of the utilization of the issue proceeds based on information provided by the issuer and information obtained from sources believed to be accurate and reliable.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Monitoring Agency Report for the quarter ended September 30,2026

Attachments (1)

📄

PARACABLES_10112026111035_MonitoringAgencyReport.pdf

pdf

Download →
View document text
(R PARAMOUNT WIRES & CABLES Date:10.11.2026 The Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, C-1, G-Block, Bandra-Kurla Complex, Dalal Street, Mumbai, MH-400001 Bandra (East), Mumbai, MH-400051 Svmbol/Scrip Code: (BSE)530555/(NSE) PARACABLES Subject: Monitoring Agency Report for the quarter ended September 30, 2026 Dear Sir / Madam, Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, enclosed herewith is the Monitoring Agency Report for the quarter ended September 30, 2026 issued by CARE Ratings Limited, Monitoring Agency for the utilization of the proceeds raised through Preferential issue of Equity Shares and unlisted convertible ‘warrants. The aforesaid information is also being made available on the website of the Company at https://paramountcables.com/ This is for your information and record. Yours sincerely, For Paramount Communications Limited Rashi Goel Company Secretary & Compliance Officer FCS 9577 Paramount Communications Ltd Paramount House KH - 433, Maulsari Avenue, Westend Greens, Rangpuri, New Delhi - 110037, India t: 491 1145618800 pel@paramountcables.com www.paramountcables.com CIN: L74899DL1994PLCO61295 No. CARE/NRO/GEN/2026-27/1165 The Board of Directors Paramount Communications Limited KH-433, Maulsari Avenue, Westend Greens, Rangpuri New Delhi 110037 November 06, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the Preferential issue of Equity shares and Fully Convertible warrants of Paramount Communications Limited (“the Company”) We write in our capacity of Monitoring Agency for the Preferential Issue for the amount aggregating to Rs. 122.63 crore (Preferential issue of equity share: Rs. 92.39 crore and Preferential issue of fully convertible share warrants: Rs.30.24 crore) of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated May 18, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sandeep Aggarwal Associate Director Sandeep.aggarwal@careedge.in CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Paramount Communications Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: No (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Sandeep Aggarwal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issue Details: Name of the issuer : Paramount Communications Limited Name of the promoter : Sanjay Aggarwal and Sandeep Aggarwal Industry/sector to which it belongs : Cables - Electricals 2) Issue Details Issue Period (Equity shares) : May 13, 2026, to July 01, 2026 Issue Period (Share warrants) : 18 months from the date of allotment (Date of allotment: July 01, 2026) Type of issue (public/rights) : Preferential Issue Type of specified securities : Equity shares and fully convertible warrants IPO Grading, if any : Not applicable Issue size of equity shares (in crore) : Rs. 92.39 crore Issue size of share warrants (in crore) : Rs. 30.24 crore CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency Board of Directors Monitoring Agency for preparation of report Vide Members resolution dated June During Q2FY27, the company has utilized Rs. 73.39 06, 2026 the term “Board” includes any crore as per the objectives mentioned in the private committee(s), which the Board has placement offer. constituted or may constitute to exercise its powers, including the ^During Q2FY27, the Company utilised Rs.9.00 crore powers conferred on the board by this towards General Corporate Purposes (GCP) for resolution i.e., special resolution dated operational expenses, including Customs House Agent June 06, 2026. (CHA) services and bank charges. As per the offer In view of above, the banking Finance document, the manner and proportion of utilisation of Committee of the Board has passed CA certificate*, Whether all utilization is as per the funds under GCP require Board approval. In support of the resolution dated July 01, 2026, for Yes^ Management certificate, disclosures in the Offer Document? the utilization under GCP during Q2FY27, the Company utilization of proceeds under general [Showing first 8,000 characters — download PDF for full document]